Drugs / Fluticasone foroate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00625196 | Feb → May 2008 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone foroate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00625196 ↗ |
| Route | Inhaled | “Fluticasone foroate 800 micrograms will be available as dry powder inhaler.” NCT00625196 ↗ |